Implication of microRNAs in the development and potential treatment of radiation-induced heart disease

Can J Physiol Pharmacol. 2017 Oct;95(10):1236-1244. doi: 10.1139/cjpp-2016-0741. Epub 2017 Jul 5.

Abstract

Radiotherapy is the most commonly used methodology to treat oncological disease, one of the most widespread causes of death worldwide. Oncological patients cured by radiotherapy applied to the mediastinal area have been shown to suffer from cardiovascular disease. The increase in the prevalence of radiation-induced heart disease has emphasized the need to seek new therapeutic targets to mitigate the negative impact of radiation on the heart. In this regard, microRNAs (miRNAs) have received considerable interest. miRNAs regulate post-transcriptional gene expression by their ability to target various mRNA sequences because of their imperfect pairing with mRNAs. It has been recognized that miRNAs modulate a diverse spectrum of cardiac functions with developmental, pathophysiological, and clinical implications. This makes them promising potential targets for diagnosis and treatment. This review summarizes the recent findings about the possible involvement of miRNAs in radiation-induced heart disease and their potential use as diagnostic or treatment targets in this respect.

Keywords: free radicals; inflammation; maladie cardiaque entraînée par des rayonnements; microARN; microRNA; oxidative stress; radiation-induced heart disease; radicaux libres; stress oxydatif.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation
  • Genetic Markers
  • Genetic Therapy / methods*
  • Heart Diseases / diagnosis
  • Heart Diseases / genetics*
  • Heart Diseases / metabolism
  • Heart Diseases / therapy*
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Molecular Diagnostic Techniques
  • Myocardium / metabolism
  • Myocardium / pathology
  • Predictive Value of Tests
  • Radiation Injuries / diagnosis
  • Radiation Injuries / genetics*
  • Radiation Injuries / metabolism
  • Radiation Injuries / therapy*

Substances

  • Genetic Markers
  • MicroRNAs